Table 2.

Predicted Probability of Acute Phase Depression Treatment and Outcomes by Patient Characteristics (N = 2010)

	Depression Treatment Quality Indicators		Acute Phase Outcomes
Characteristics	Received Follow-Up Within 21 Days	Received Appropriate Pharmacotherapy	12-Week Outcome Measured	Depression Improved †
Age = 20	57.0%	45.4%	34.6%	59.7%
Age = 40	55.2%	49.9%	39.5%	54.4%
Age = 60	53.4%	54.5%	44.8%	49.0%
Age = 80	51.6%	59.0%	50.6%	43.6%
Gender = Male	51.8%	49.0%	37.4%	55.7%
Gender = Female	55.4%	51.4%	41.5%	52.5%
Preferred Language = English	54.7%	53.2%	41.1%	48.5%
Preferred Language = Spanish	54.8%	48.1%	40.6%	59.1%
Baseline OASIS Score
Low (Mean − SD)	50.7%	43.3%	39.1%	61.1%
Average (Mean)	54.8%	51.0%	40.7%	53.1%
High (Mean + SD)	58.8%	58.7%	43.0%	45.0%
Baseline PHQ-9 Group
Mild (5–9)	51.0%	42.0%	33.4%	59.9%
Moderate (10–14)	54.4%	49.7%	39.1%	48.3%
Severe (15–27)	55.6%	53.1%	42.8%	53.8%

Predicted probabilities are adjusted for all remaining variables in the table (age, gender, preferred language, baseline OASIS score and baseline PHQ group)

^†Percentage of patients with 12-Week Measurement (N = 1063)